InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: biomanbaba post# 4470

Tuesday, 10/30/2012 8:00:48 PM

Tuesday, October 30, 2012 8:00:48 PM

Post# of 16750
In the past 6 years, approvals received through the 505(b)(2) pathway have consistently outnumbered "de novo" NDAs. http://bit.ly/ThPPE6

Highly relevant in CLSN situation as TDOX approval will be filed under 505 and fast tracked.